MarketFriction

RPG Life Sciences Ltd

NSE RPGLIFE · BSE 532983 · Pharmaceuticals
₹2,930.70 -3.50%
NSE close2026-10-01
52 week range1,733.00 - 3,127.80
Market cap₹5,109 Cr.
P/E43.8
Price band 20% Delivery 44.3%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales154154127165172173143169182180177196
Expenses116116106126126124118133143140144152
Operating Profit373821394649253539403344
OPM %24%25%16%24%27%28%18%21%21%22%19%22%
Other Income2222-253115516-5134
Interest000000000001
Depreciation444555555566
Profit before tax3536183615471353549294041
Tax %26%26%25%26%72%26%13%26%25%24%26%26%
Net Profit262613274351172637223031
EPS in Rs15.6416.008.0116.182.5421.1270.9515.9022.2813.3818.0818.48
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales279294344330376389440513582653708734
Expenses256274306296315318353408453493560579
Operating Profit23203834607187104129161148155
OPM %8%7%11%10%16%18%20%20%22%25%21%21%
Other Income11811-51347952928
Interest245532111221
Depreciation101114151616161617212122
Profit before tax1223201536547392118233154160
Tax %0%10%34%28%20%25%30%26%26%21%25%
Net Profit122113112940516888183115119
EPS in Rs7.0312.708.136.5417.5424.1931.1340.9053.00110.7969.6472.22
Dividend Payout %23%22%30%37%23%30%31%29%30%22%34%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth10%13%11%12%
Compounded Profit Growth25%22%17%13%
Stock Price CAGR20%35%34%38%
Return on Equity20%23%23%19%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital131313131313131313131313
Reserves112120134142147163203243294362517592
Borrowings3323455436122100020
Other Liabilities3949558254788588112138127168
Total Liabilities197205247291251267303345419513658793
Fixed Assets105109137131128123113104124114172197
CWIP12291710123125961623
Investments000000005891127120
Other Assets9294108152106134178210211212343454
Total Assets197205247291251267303345419513658793
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-2337154650586591947856
Cash from Investing Activity-10-15-30-16-19-11-8-35-106-79-4251
Cash from Financing Activity12-18230-26-39-10-14-17-20-27-21
Net Cash Flow-0-01-1004017-32-5987
Free Cash Flow-1218-48-1263950415825151-9
CFO/OP14%150%58%48%144%94%94%96%111%96%81%63%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days614849724362542727314860
Inventory Days149156163171136133162214203200159179
Days Payable10913510216583127132117138140135141
Cash Conversion Cycle101701107896688412491907299
Working Capital Days272620222041524733254564
ROCE %2%9%10%13%10%23%27%31%33%35%33%26%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters72.82%72.82%72.82%72.82%72.82%72.95%72.95%72.95%72.95%72.95%72.95%72.95%
FIIs0.46%0.56%0.90%1.15%1.35%1.30%1.46%1.35%1.11%1.00%0.87%0.95%
DIIs1.57%1.77%2.16%2.61%5.45%6.06%6.14%6.49%6.70%7.04%7.45%8.68%
Public25.15%24.85%24.12%23.44%20.40%19.70%19.46%19.22%19.23%19.01%18.72%17.42%
No. of Shareholders21,08821,86622,13722,23223,48124,89124,86725,83226,65725,90525,28223,886

Fundamentals

Market Cap₹ 5,109 Cr.
Current Price₹ 3,089
Stock P/E43.8
Book Value₹ 366
ROCE25.7 %
ROE19.3 %
Dividend Yield0.78 %
Face Value₹ 8.00
Compounded Sales Growth (TTM)12%
Compounded Profit Growth (TTM)13%
Standalone figures.
Valuation
Market capRs 4,847 Cr
Enterprise valueRs 4,710 Cr
P/E (TTM)40.58x
Price to book8.01x
Price to sales6.60x
EV / EBITDA25.65x
EV / EBIT29.19x
EV / sales6.41x
Price to cash flow85.79x
Earnings yield2.46%
Dividend yield0.82%
P/E, 3-year average25.37x
P/B, 3-year average6.31x
P/E, 5-year average22.25x
P/B, 5-year average5.26x
Profitability
Operating margin (excl. other income)20.92%
Operating margin (incl. other income)25.08%
EBITDA margin25.01%
Pre-tax margin21.79%
Net profit margin16.27%
Net margin, latest quarter15.62%
ROE20.28%
ROCE26.99%
ROA15.88%
ROE, 3-year average28.82%
ROCE, 3-year average37.91%
ROA, 3-year average22.00%
ROE, 5-year average26.45%
ROCE, 5-year average35.61%
ROA, 5-year average19.92%
ROIC (approx.)25.72%
Tax rate25.31%
Other income / net worth4.86%
Growth
Sales growth (latest year)8.28%
Profit growth (latest year)-37.15%
Sales CAGR, 3 years11.33%
Sales CAGR, 5 years12.70%
Profit CAGR, 3 years19.41%
Profit CAGR, 5 years23.55%
Sales growth QoQ10.63%
Profit growth QoQ2.24%
Sales growth YoY (latest quarter)15.85%
Profit growth YoY (latest quarter)16.28%
Per share
EPS (TTM)Rs 72.22
EPS (latest year)Rs 69.64
EPS (latest quarter)Rs 18.48
EPS, 3-year averageRs 77.81
EPS, 5-year averageRs 61.09
Book value per shareRs 366.03
Sales per shareRs 443.97
Cash flow per shareRs 34.16
Free cash flow per shareRs -5.44
Dividend per share (latest year)Rs 24.00
Dividend per share, 3-year averageRs 21.33
Dividend per share, 5-year averageRs 17.12
Dividends
Dividend payout34.46%
Dividend payout, 3-year average28.77%
Dividend payout, 5-year average29.30%
Efficiency
Asset turnover0.89x
Fixed asset turnover3.60x
Inventory turnover2.42x
Inventory days151 days
Debtor days60 days
Debtors turnover6.06x
Creditor days141 days
Cash conversion cycle99 days
Working capital days64 days
Leverage
Total debtRs 20 Cr
Cash and bankRs 157 Cr
Net debtRs -137 Cr
Debt to equity0.03x
Net debt / EBITDA-0.74x
Interest coverage116.09x
Current ratio (filing 2026-03-31)3.30x
Quick ratio (filing 2026-03-31)2.53x
Trade payables (filing 2026-03-31)Rs 97 Cr
Owners' fund to total sources76.33%
Debt to assets2.52%
Cash flow
Cash from Operating Activity (latest year)Rs 56 Cr
Cash from Investing Activity (latest year)Rs 51 Cr
Cash from Financing Activity (latest year)Rs -21 Cr
Net Cash Flow (latest year)Rs 87 Cr
Free cash flow (latest year)Rs -9 Cr
Cash from ops / profit, 5 years0.76x
Sales to cash flow12.52x
Statement figures
Net sales (TTM)Rs 734 Cr
Net sales (latest year)Rs 708 Cr
Sales (latest quarter)Rs 196 Cr
Operating profit excl. other income (latest year)Rs 148 Cr
Operating profit (latest quarter)Rs 44 Cr
Other income (TTM)Rs 28 Cr
EBITDA (TTM)Rs 184 Cr
PBDT (TTM)Rs 182 Cr
Profit before tax (TTM)Rs 160 Cr
Tax (latest year)Rs 39 Cr
Net profit (TTM)Rs 119 Cr
Net profit (latest year)Rs 115 Cr
Net profit (latest quarter)Rs 31 Cr
Depreciation (TTM)Rs 22 Cr
Depreciation (latest quarter)Rs 6 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 300 Cr
Total expenditure (latest year)Rs 560 Cr
Total income (latest year)Rs 737 Cr
Share capitalRs 13 Cr
ReservesRs 592 Cr
Shareholders' fundsRs 605 Cr
Total assetsRs 793 Cr
Net blockRs 197 Cr
Capital work in progressRs 23 Cr
InvestmentsRs 120 Cr
ReceivablesRs 117 Cr
InventoryRs 124 Cr
Other liabilitiesRs 168 Cr
Shares outstanding (crore)1.65
Ownership
Promoter holding72.95% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 40.6 is at the 88th percentile of its own 9.4-year range (median 28.4, low 15.2, high 47.8).
P/B 8.01 is at the 85th percentile (median 4.72).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodRPGLIFENifty 50Difference
1 week+1.1%-2.8% +3.8 pts
1 month+13.1%-6.8% +19.9 pts
3 months+21.3%-7.6% +28.9 pts
6 months+57.8%+0.4% +57.4 pts
1 year+22.1%-9.9% +32.0 pts
2 years+33.1%-13.6% +46.7 pts
3 years+126.6%+14.2% +112.4 pts
5 years+330.9%+27.9% +303.0 pts
3 mutual fund schemes hold about ₹2 Cr. Over three months 0 bought more and 2 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Unifi Flexi Cap Fund0.73%2 -20%
Bandhan BSE Healthcare Index Fund0.07%0 -11%
Motilal Oswal BSE 1000 Index Fund0.01%0

Red flags

F-score 3 of 8
explainReceivables outrunning sales Receivables grew 34% vs sales +8% in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2026-09-25Clarus Capital I, Clarus Capital IAcquirerbuy37,463SAST Open Market
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹196 Cr +16.0% vs Jun 2025. Net profit ₹31 Cr +19.2%.
Against our estimate for Jun 2026: sales +1.8%, profit -0.4% in line. Our estimate for Sep 2026: sales Rs 218 Cr, profit Rs 36 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-09Dividend - Rs 24 Per Share
2025-06-27Dividend - Rs 20 Per Share/ Special Dividend - Rs 4 Per Share
2024-06-28Dividend - Rs 16 Per Share
2023-07-21Dividend - Rs 12 Per Share
2022-07-14Dividend - Rs 9.60 Per Share
2021-08-13 Dividend - Rs 7.20 Per Share
2020-03-24 Interim Dividend - Rs 4 Per Share
2019-07-22 Annual General Meeting/ Dividend - Rs 2.40 Per Share
2018-07-19 Annual General Meeting/Dividend- Rs 2.40 Per Share
2017-07-13 Annal General Meeting/Dividend - Rs 2.80 Per Share
2016-07-19 Annual General Meeting
2016-03-22 Interim Dividend - Rs 1.60/- Per Share
2015-07-20Annual General Meeting And Dividend Re.0.80 Per Share
2014-09-11Annual General Meeting / Dividend - Rs 1.20/- Per Share + Special Dividend - Re 0.80/- Per Share
2013-07-11Annual General Meeting / Dividend - Rs 1.20/- Per Share
2012-07-24Annual General Meeting/ Dividend Rs. 0.80 Per Share
2011-07-14Annual General Meeting And Dividend Rs.1.60 Per Share
2010-07-15Annual General Meeting And Dividend Rs.1.44 Per Share
2009-07-30Agm/Div-Rs.1.20 Per Share
2008-08-11Agm/Dividend - 15%
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
Trade dateShares sold short
2026-09-292
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of RPG Life Sciences Ltd?

RPG Life Sciences Ltd (RPGLIFE) has a market capitalisation of Rs 5,109 Cr. at the 2026-10-01 close.

What is the P/E ratio of RPG Life Sciences Ltd?

RPG Life Sciences Ltd trades at a P/E of 43.8 on trailing twelve-month profit, at the 2026-10-01 close.

What were RPG Life Sciences Ltd's latest quarterly results?

In the Jun 2026 quarter, RPG Life Sciences Ltd sales was Rs 196 Cr (+16.0% vs Jun 2025) and net profit was Rs 31 Cr.

What is the 52-week high and low of RPG Life Sciences Ltd?

The 52-week high is Rs 3,127.80 and the 52-week low is Rs 1,733.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03